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ABSTRACT
The engineering of biological components has been
facilitated by de novo synthesis of gene-length
DNA. Biological engineering at the level of
pathways and genomes, however, requires a
scalable and cost-effective assembly of DNA mole-
cules that are longer than  10kb, and this remains a
challenge. Here we present the development of
pairwise selection assembly (PSA), a process that
involves hierarchical construction of long-length
DNA through the use of a standard set of compo-
nents and operations. In PSA, activation tags at the
termini of assembly sub-fragments are reused
throughout the assembly process to activate
vector-encoded selectable markers. Marker activa-
tion enables stringent selection for a correctly
assembled product in vivo, often obviating the
need for clonal isolation. Importantly, construction
via PSA is sequence-independent, and does not
require primary sequence modification (e.g. the
addition or removal of restriction sites). The utility
of PSA is demonstrated in the construction of a
completely synthetic 91-kb chromosome arm from
Saccharomyces cerevisiae.
INTRODUCTION
De novo synthesis of DNA is becoming an increasingly
valuable resource for a broad range of applications (1).
While synthesis of gene-length DNA (1–3kb) is common,
the ability to quickly and cost-eﬀectively assemble
longer-length DNA (>10kb) remains a challenge. The
process of synthetic DNA construction typically involves
the assembly of overlapping oligonucleotides into contig-
uous fragments of dsDNA using PCR-based and/or
ligation-based methods (2–5). The products of these
assemblies generally require extensive clonal screening and
sequence-veriﬁcation to avoid mis-assembled products
or products containing errors due to imperfect oligo-
nucleotide ﬁdelity. Coupling oligonucleotide assembly
with error-ﬁltration methods (5–7) aids in the production
of higher ﬁdelity synthetic DNA, but there remains a need
for scalable technologies for subsequent assembly of sub-
fragments to create longer-length DNA.
Several methods have been developed for downstream
assembly of synthetic DNA to create multigene pathways
or chromosome-sized molecules. PCR-based approaches
have been used to assemble fragments up to  20kb (8),
but have been shown to have limited utility for construc-
tion of larger DNA fragments (8), and are generally less
practical for construction of sequences with high GC
content or repeat regions. Ligation-based methods avoid
some of the sequence-dependent issues associated with
PCR-based assembly, and have been used to construct
large viral genomes (9) and gene clusters up to 32kb
(10). Some ligation-based methods have been developed
to use common sets of restriction sites and vectors for
modular (11) or hierarchical (12,13) assembly of DNA
sub-fragments. All of these ligation-based assembly
methods require the insertion and/or removal of restric-
tion sites that are used in the assembly process from the
primary sequence being assembled. The necessity for
sequence modiﬁcation is non-ideal, as the phenotypic
eﬀects of such modiﬁcations are diﬃcult to predict, and
can be detrimental (14).
Recently, recombination-based methods were used to
construct a 134-kb fragment in Bacillus subtilis (15), and
a 583-kb fragment in Saccharomyces cerevisiae (16,17).
While these assemblies demonstrate the feasibility of
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(16,17), they either involve stepwise assembly (15), or
rely on the absence of a particular restriction site
(16,17), potentially limiting their scalability. A one-step,
in vitro recombination method was also recently developed
and used to assemble DNA products as large as 900kb
in vitro (18). This simple and rapid method was used to
join two  150-kb fragments with an 8-kb vector, and,
after transformation of Escherichia coli with an assembly
product, approximately 50% of the colonies screened con-
tained the correct insert size (18).
The diﬃculty in scaling conventional methods, together
with the high cost of screening and validation of construct
intermediates, hinders the reliable and cost-eﬀective con-
struction of long-length DNA. Here we present a general,
fundamentally scalable method for the construction of
long DNA sequences. This method, termed pairwise selec-
tion assembly (PSA), is a ligation-based assembly method
that uses a standard set of components and operations for
hierarchical DNA assembly that is ‘sequence-
independent’. Importantly, PSA does not require
sequence modiﬁcation to accommodate the construction
method (e.g. through the addition or removal of restric-
tion sites) and uses stringent selection to minimize the
screening of assembly intermediates.
The basic components of PSA include two cassettes that
encode divergently oriented, non-functional antibiotic
resistance markers and a corresponding set of two
recyclable activation tags. Activation tags ﬂank all initial
sub-fragments and serve two functions: (i) they enable
positive selection of a paired ligation product through
activation of cassette-encoded antibiotic resistance
markers, and (ii) they contain sites for type IIS restriction
enzymes that allow sub-fragment excision throughout the
assembly process (because type IIS restriction enzymes cut
outside of their recognition sequence, one activation tag
from each sub-fragment is recycled for use in the next
assembly round). Figure 1 illustrates the assembly of
four sub-fragments over two PSA levels. At each
assembly level, each sub-fragment is digested with one of
two type IIS restriction enzymes (whose cognate sites are
located within the activation tags) such that only one acti-
vation tag is retained (indicated by U-shaped arrows in
Figure 1). This ensures that both sub-fragment members
of a pair are necessary for activation of the selectable
markers in the destination assembly vector. Sub-fragments
from one vector type (e.g. containing selectable markers A
and B) become a joined product in the second vector type
(e.g. containing selectable markers C and D) (Figure 1).
This enables a stringent selection of correctly ligated pairs,
obviating the need for sub-fragment puriﬁcation prior to
ligation, and, in a majority of assemblies, enables selection
directly in culture (i.e. without clonal isolation via
plating). Products of one assembly level become sub-
fragments of the next level of assembly, and assembly
proceeds until the full-length product is constructed.
In PSA, the fundamental operations performed on two
sub-fragments to be joined are not dependent on the
sequence being constructed, and do not change through-
out the assembly process. The utility of PSA was
demonstrated in the construction of a completely synthetic
91-kb right arm of chromosome IX from S. cerevisiae
(nucleotide sequence and description of the synthetic
91-kb chromosome arm, termed synIXR, is described else-
where by J.S. Dymond et al., High Throughput Biology
Center, Johns Hopkins University School of Medicine,
submitted for publication).
MATERIALS AND METHODS
Strategy for long DNA construction via PSA
In PSA, a target sequence is ﬁrst broken down into a set of
initial sub-fragments that are synthesized with small,
recyclable tags on their termini. These tags activate
vector-encoded antibiotic resistance in one of two
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Figure 1. Pairwise selection assembly. A target assembly sequence is broken down into sub-fragments (I–IV) that are synthesized with ﬂanking tags
(grey arrows). At PSA level 0, sub-fragments are inserted into one of two PSA vectors where tags activate two, divergently oriented selectable
markers (A and B). Level 0 sub-fragment pairs are excised so that only one activation tag is retained for each sub-fragment. Subsequent pair ligation
occurs in a second PSA vector where tags activate a second set of selectable markers (C and D), producing a PSA level 1 product. This hierarchical
process is repeated, switching between two vectors with diﬀerent selectable markers, until the full-length product is assembled.
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marker cassettes. A hierarchical build tree is generated
where the number of levels in the tree scales as the
binary logarithm of the initial number of sub-fragments,
and each level consists of a ﬁxed number of sub-fragment
pairs (Figure 1). If the initial number of sub-fragments (Fi)
is not a power of two, then a subset of initial
sub-fragments is built into one vector type (VAB) while
the remaining sub-fragments are built into the second
vector type (VCD) so that Fi=VAB+VCD, and
VAB ¼ 2n   Fi, where
n ¼ log2 Fi ðÞ

:
This breakdown simpliﬁes the build tree by ensuring
that after the ﬁrst assembly level, the number of
sub-fragments is a power of two (i.e. all sub-fragments
will be members of a pair in all remaining assembly levels).
DNA synthesis and vector construction
CK and TS cassettes and all 64 sub-fragments of the 91-kb
synthetic sequence, including ﬂanking activation tags,
were constructed from synthesized oligonucleotides using
Codon Devices’ BioFAB
TM platform. CK and TS cas-
settes were inserted between AatII and SapI sites of
pUC19, retaining the origin of replication and ampicillin
resistance marker, to create pCK and pTS, respectively.
pCKBAC and pTSBAC were constructed by inserting
DraI-digested fragments of pCK and pTS (containing
the cassette regions and the bla gene) between HpaI and
BstZ17I sites of pBeloBAC11. BsmBI and BsaI sites in the
remaining pBeloBAC11 backbone were removed by
site-directed mutagenesis.
Strains, growth and DNA preparation
Escherichia coli strain DH10B (F-mcrA (mrr-hsdRMS-
mcrBC) u80lacZM15 lacX74 recA1 endA1 araD139 
(ara, leu)7697 galU galK  -rpsL nupG /pMON14272/
pMON7124, Invitrogen) was used for all experiments.
Cells were grown in LB media (Difco) with appropriate
antibiotic combinations: pCK or pCKBAC clones were
grown with 12.5mg/ml chloramphenicol and 25mg/ml
kanamycin; pTS or pTSBAC clones were grown with
5mg/ml tetracycline and 100mg/ml spectinomycin.
Cultures were grown at 37 C and 300rpm for 15–30h,
and plates were grown at 37 C for 18–48h.
For high-throughput processing of inputs for PSA
rounds 1–3, a Qiagen BioRobot 8000 automated
workstation using a QIAPrep 96 Turbo BioRobot kit
was used for DNA preparation, and DNA quantiﬁcation
was performed using a SpectraMax M5 plate reader
(Molecular Devices). Custom software was written to nor-
malize DNA concentration to 50ng/ml using the Qiagen
BioRobot workstation and a Savant ISS110 SpeedVac
concentrator. The Qiagen BioRobot 8000 transfers
500ng (10–50ml) from the initial DNA prep plate to a
normalization plate that is placed in the SpeedVac
concentrator; DNA is then resuspended in 10mld H 2O.
For the smaller number of inputs to PSA rounds 4–6, a
QIAprep Spin Miniprep kit (Qiagen) or a QIAGEN
Plasmid Maxiprep kit (Qiagen) were used for high-copy
and low-copy backbones, respectively, and a Nanodrop
ND-1000 Spectrophotometer was used for DNA
normalization.
RecA-mediated blocking and PSA
All enzymes and buﬀer solutions were from New England
Biolabs (NEB). PSA sub-fragments undergo a four-step
process prior to ligation that includes (i) RecA polymer-
ization of blocking oligonucleotides, (ii) D-loop forma-
tion, (iii) methylation and (iv) digestion. Blocking
oligonucleotides (Supplementary Table S1) are incubated
with RecA at a nucleotides:RecA ratio of 3:1 in a 15ml
polymerization reaction that includes 3mg RecA, 0.27mM
blocking oligo mix (2 pmol each oligo) and 0.67mM
ATPgS (Sigma) in NEB buﬀer 2 (50mM NaCl,
10mM Tris–HCl, 10mM MgCl2, 1mM DTT). The poly-
merization reaction is incubated at 37 C for 20min. After
RecA polymerization, 9ml of normalized plasmid DNA
(450ng) and 1mlo f1 0  NEB buﬀer 2 are added to the
reaction, and incubated an additional 30min at 37 C for
D-loop formation. A 5ml methyltransferase mix of
0.5 units M.SssI and 3200pmol S-adenosylmethionine
(SAM) in NEB buﬀer 2 is then added directly to the
reaction, and incubated at 37 C for an additional 3–4h.
The 30ml reaction is then heated to 60 C for 25min to
inactivate the RecA protein, and either 1 unit of BsmBI
(L sub-fragments), or 2 units of BtgZI (R sub-fragments)
are added directly to the reaction. Digestion proceeds
at 55 C for 50min, and the enzymes are then
heat-inactivated at 80 C for 25min. In the three problem-
atic cases where a sub-fragment junction matched a vec-
tor overhang, alkaline phosphatase (5 units) was added
directly to the digest of the sub-fragment with direc-
tional, matching ends (L sub-fragment if TGAG
junction, R sub-fragment if TTCA junction). In these
cases, alkaline phosphatase was also used in the
linearization of the destination vector to remove the 50
phosphate from the vector overhang that matched the
sub-fragment junction.
Pair ligations include equal volumes of each heat-
inactivated sub-fragment reaction (3–6ml), 200 units T4
DNA ligase and 40ng of linearized PSA vector in T4
buﬀer (50mM Tris–HCl, 10mM MgCl2, 1mM ATP,
10mM DTT). When necessary, a QIAquick Gel
Extraction kit (Qiagen) was used to purify digested sub-
fragments prior to ligation. Ligations were incubated at
room temperature for 0.5–3h, or at 16 C for 12–16h.
Chemically competent DH10B cells (Invitrogen) were
transformed with assemblies for PSA levels 1–4,
and electrocompetent DH10B cells (Invitrogen) were
transformed via electroporation with assemblies for
PSA levels 5–6 using a BTX ECM630 (BTX Harvard
Apparatus) and 1mm gap cuvettes (BTX). Both transfor-
mation procedures followed the manufacturer’s instruc-
tions. For PSA levels 5 and 6, a simple de-salting
step (19) was added prior to both ligation and
electroporation.
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Prepped PSA product was analyzed by restriction diges-
tion and agarose gel electrophoresis. At PSA level 3, all
constructs were sequenced prior to further assembly using
an ABI 3730 DNA Analyzer and BigDye Terminator
reagent. The ﬁnal, 91-kb construct was analyzed by ﬁeld
inversion gel electrophoresis (FIGE) with a BioRad FIGE
MAPPER running program 3 (switch time ramp 0.1–2s,
linear shape, forward voltage 180V, reverse voltage 120V,
16h run time). Two full-length clones selected either in
culture or clonally on an LB agar plate were sequenced.
A  300bp region of the full-length product was highly
repetitive and not covered by high quality sequencing
reads (see J.S. Dymond et al., submitted for publication).
RESULTS
PSA component design
Two cassettes containing divergently-oriented, non-
functional antibiotic resistance markers were synthesized.
Chloramphenicol and kanamycin resistance markers were
incorporated into a ‘CK’ cassette, while tetracycline and
spectinomycin resistance markers were incorporated into a
‘TS’ cassette (Supplementary Table S1). Both cassettes
were designed so that the incorporated antibiotic resis-
tance markers lack promoter elements, are separated by
a 20-base intergenic region containing abutting BsaI–
NotI–BsmBI restriction sites, and have modiﬁed TTG
start codons (Figure 2a). Digestion with BsaI and
BsmBI excises the intergenic DNA, including the initial
thymine base of the modiﬁed TTG start codons, leaving
four-base, 50 overhangs. In both cassettes, a BsaI cut
produces a 50-TTCA overhang, while a BsmBI cut
produces a 50-CTCA overhang (Figure 2a). Importantly,
the ﬁrst amino acid downstream of the start codon in the
chloramphenicol resistance marker was mutated from
glutamic acid to asparagine (GAG>AAC) so that the
four-base overhang produced at the chloramphenicol
end is identical to the overhang produced at the tetracy-
cline end. Identical overhangs for each cassette are neces-
sary for seamless transition from one cassette to the other
as PSA progresses from one assembly level to the next.
CK and TS cassettes were inserted in a pUC19
backbone creating the high-copy pCK and pTS vectors,
respectively (Figure 2a). To enable PSA-based construc-
tion of DNA fragments larger than those carried eﬃ-
ciently by high-copy vectors, a second set of single-copy
PSA vectors were created by inserting the CK and TS
cassettes into a BAC-based vector, creating pCKBAC
and pTSBAC. Both sets of vectors were veriﬁed as not
conferring resistance to the working concentrations of
chloramphenicol and kanamycin (12.5 and 25mg/ml,
respectively), or tetracycline and spectinomycin (5 and
100mg/ml, respectively).
Short activation tags located at the termini of each
sub-fragment to be assembled via PSA contain
divergently-oriented promoters designed to activate other-
wise non-functional markers in pCK or pTS vector
cassettes. These  65bp tags diﬀer in sequence content
(to avoid inverted repeats), and are designed to promote
eﬃcient expression in E. coli based on the architecture of
s
70 promoters (20). Restriction sites for two type IIS
enzymes, BsmBI and BtgZI, are embedded within each
promoter so that overhangs generated by digestion at
sites proximal to the antibiotic resistance markers are
compatible with overhangs generated by linearization of
pCK or pTS, while digestion at sites distal to the markers
produces compatible overhangs between adjacent
sub-fragments (Figure 2b).
The pairing of two pCK sub-fragments in a pTS vector
is illustrated in Figure 2c. The upstream, or ‘left’ pCK
sub-fragment (L) is digested with BsmBI to retain the
upstream activation tag, and the downstream, or ‘right’
pCK sub-fragment (R) is digested with BtgZI to retain the
downstream activation tag. Overhangs created at the pCK
cassette-tag junctions are compatible with linearized pTS.
Sub-fragments are synthesized with 4bp overlaps to
ensure that the overhangs created at the junction
between sub-fragments are compatible. After ligation
and transformation, a correctly paired product will
activate tetracycline and spectinomycin antibiotic resis-
tance markers, enabling in vivo selection. The paired
product in pTS now has ﬂanking activation tags and
becomes an L or R sub-fragment for downstream
assembly in a pCK vector. The digestion–ligation–selec-
tion process is repeated until the desired DNA sequence
has been constructed.
Because the activation tags are recycled, and the
embedded BsmBI and BtgZI sites are used to excise
L and R sub-fragments throughout the assembly
process, it is important that these sites are made to be
unique. Each non-palindromic six-base recognition
sequence would be expected to be present at a frequency
of 1/2048bp, normally necessitating modiﬁcation of the
internal restriction sites prior to assembly, or requiring
the use of alternate rare cutters. To avoid this issue, a
RecA-assisted cleavage technique (21,22) is used to
block restriction at sites located within the sequence
being assembled (Figure 2c). Two sets of universal
blocking oligonucleotides (Supplementary Table S2),
designed with complementarity to the activation tag
regions, form a RecA-mediated structure that blocks
DNA methylation by CpG methyltransferase. The
BsmBI and BtgZI enzymes chosen for use in PSA are sen-
sitive to CpG methylation (23), enabling selective cleavage
at the blocked sites within the activation tags upon
removal of the RecA complex (Figure 2c). This process
allows the use of a single set of enzymes to eﬀectively
excise full-length sub-fragments throughout the assembly
process, regardless of whether or not the sites are present
in the sequence being assembled.
Assembly of a synthetic 91-kb S. cerevisiae chromosome
arm via PSA
A designed 91010bp right arm of S. cerevisiae chromo-
some IX termed synIXR (J.S. Dymond et al., submitted
for publication) was broken down into 64 sub-fragments
averaging  1500bp. Sub-fragments were constructed with
ﬂanking activation tags and were sequence-veriﬁed in
Nucleic Acids Research,2010, Vol.38, No. 8 2597pCK vectors. A hierarchical build tree (Figure 3a) illus-
trates the 63 pairing reactions spanning six PSA levels
necessary for assembly of the full-length product. All
level 0 L and R sub-fragments in pCK vectors were
blocked and methylated (regardless of whether or not an
internal site was present), digested and mixed with
linearized pTS in a ligation (see ‘Materials and Methods’
section). The reaction mix diﬀered for L and R
sub-fragments only in terms of the blocking oligos and
restriction enzymes used. Importantly, the restriction
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Figure 2. PSA components and assembly scheme. (a) Two PSA cassettes contain non-functional chloramphenicol (cam
R) and kanamycin (kan
R), or
tetracycline (tc
R) and spectinomycin (spn
R) resistance markers that are separated by abutting BsaI, NotI and BsmBI sites. Cassettes are inserted in
high-copy and single-copy backbones to create pCK and pTS or pCKBAC and pTSBAC, respectively. The arrows and dotted lines show restriction
sites for the type IIS BsaI and BsmBI enzymes that cut outside of their recognition sequences. (b) Flanking activation tags are composed of E. coli
promoters embedded with BsmBI and BtgZI restriction sites which, when digested, retain either the L (BsmBI digest) or R (BtgZI digest) tag for
activation of vector-encoded resistance markers (arrows and dotted lines indicate type IIS restriction sites). (c) Illustration of the steps involved in a
single PSA reaction. Universal blocking oligos (red lines), polymerized with RecA (red circles), form D-loops at complementary sites within acti-
vation tags, blocking CpG methylation. After heat inactivation of RecA, L and R sub-fragments are digested with BsmBI (blue arrows) or BtgZI
(orange arrows) so that one activation tag is retained per sub-fragment. Overhang compatibility ensures directional ligation with pTS vector
(linearized with BsaI and BsmBI), and activation of tc
R and spn
R markers. Reconstituted start codons are shown in bold, and growth in tetracycline
and spectinomycin media selects for a correctly paired product. Use of recyclable activation tags ensures that the product of a PSA reaction can be
used as either an L or R sub-fragment in a subsequent PSA reaction.
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ligation to avoid unwanted cross-digestion of the pro-
tected tag regions. Agarose gel electrophoresis of the
blocked and digested pCK sub-fragments indicates a
mixture of plasmid forms, with double-cut vector (where
the sub-fragment is excised from the backbone) as well as
single-cut vector (where one of the two target sites is not
cut) (Figure 3b, Supplementary Figures S1 and S3).
After transformation and recovery, cells were both
plated on agar plates and diluted 1:50 in liquid media
with 5mg/ml tetracycline and 100mg/ml spectinomycin.
After  16h of growth, plasmid DNA was extracted
from non-plated cultures and screened via digestion to
determine the extent of selection of the correct product
in culture. Of the 32 products formed at PSA level 1,
69% (22 products) showed a correct band pattern,
indicating selection of a homogeneous population of
correctly assembled pairs. These constructs were used as
inputs to PSA level 2, and were not clonally isolated by
picking colonies on plates (e.g. see Figure 3b). The restric-
tion digest screen of the remaining 10 products showed a
mixture of correct and incorrect bands, indicating that a
heterogeneous population had been selected. In these
cases, four colonies were picked from plates for growth,
DNA preparation and screening via digestion. Seven of
the 10 remaining products were obtained by clonal selec-
tion for a total PSA yield of 29/32 or  91% (Table 1).
The remaining 3 pairings were repeated with size-puriﬁed
fragments and correct products were obtained either by
selection in culture (2 products) or by clonal selection on
plates (1 product). A second, independent pairing of all 64
sub-fragments showed that 71% (23 products) were
successfully selected in culture as indicated by restriction
digest (Supplementary Figure S2).
This process was repeated for levels 2–4 in the PSA
build tree, switching between pTS and pCK vectors
and the associated dual antibiotic media. Yields for selec-
tion in culture for PSA levels 2–4 were 31% (5/16), 75%
(6/8) and 50% (2/4), respectively (Table 1). The lower
yield for selection in culture at PSA level 2 may have
been due to the use of a an incorrectly prepared,
low-concentration antibiotic, and a second, independent
pairing of the 32 sub-fragments with the correct antibi-
otic preparation showed that 63% (10 products) were
successfully selected in culture as indicated by restriction
digest (Supplementary Figure S4). As with level 1,
four individual colonies were selected for growth and
screening via digestion for products that were not
obtained by selection in culture. The combined yield at
PSA levels 1–4 of the correct product selected either in cul-
ture, or by picking four plated colonies, was  88% (53/60)
with an average of 2.2 screening assays for each of the
53 correct products. The success of selection of the
correctly assembled product was not dependent on
the need for restriction site blocking (due to the presence
of internal restriction site(s) in one or both of the
sub-fragments). For PSA levels 1 and 2, 55% of the 29
products that required blocking were selected in culture,
and 38% were selected on plates. A similar breakdown
was observed for the 19 products that did not have an
internal restriction site where 58% were selected in
culture and 26% were selected on plates. After PSA
level 2, all pairs had at least one sub-fragment that
required blocking.
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Figure 3. Hierarchical PSA tree and assembly of 91-kb synthetic chromosome arm. (a) 64 sub-fragments are assembled to make a single 91-kb
product over six PSA levels. Transition from one PSA level to the next involves transition between CK backbones (blue circles) and TS backbones
(red circles). Sub-fragments are labeled alphabetically (A through BL), and successive products retain the outermost label (e.g. A–B+C–D=A–D),
ensuring that all intermediates have unique identiﬁers, and order information is preserved. (b) Assembly of the AS through AV portion of the build
tree. PSA level 0 and level 1 images represent results from blocking/digestion of sub-fragments prior to assembly (asterisk for AU–AV indicates that
an internal BtgZI site was blocked); PSA level 2 image is a BsmBI digest screen of a correctly assembled product selected in culture. The same DNA
molecular weight marker (M) is used in each image.
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PSA levels, where the correct-sized product was not
obtained either by initial selection in culture, or subse-
quent screening of plated colonies. In these cases, the
correct product was obtained by repeating the PSA
process using sub-fragments that had been size-puriﬁed
via agarose gel electrophoresis prior to ligation. One
notable failure mode was the propagation of a single
sub-fragment and its corresponding tag in the destination
vector, despite the lack of the second activation tag. Of the
seven cases where a correct-sized product was not initially
obtained, there were three speciﬁc cases where ligation of a
single sub-fragment was favored due to an exact match
between the 4bp sub-fragment junction and one of the
two constant vector overhangs (Figure 2a). Although a
single sub-fragment contains only one activation tag, it
was observed that the ‘non-tag’ junction end could
activate the downstream non-functional marker, as
indicated by resistance to the associated antibiotic.
There was a single case where a sub-fragment junction
matched one of the two vector overhangs, but did not
result in propagation of a single sub-fragment. In this
case, it is notable that the sub-fragment provides a stop
codon in-frame with the associated ‘promoter-less’ antibi-
otic resistance marker 11 codons upstream from the start
codon.
To determine whether errors were incorporated either in
the assembly process, or through replication in the E. coli
host, the eight sub-fragments at PSA level 3 were
sequenced before progressing to PSA level 4. Four
errors were detected in three of the sub-fragments.
The errors occurred only at sub-fragment junctions, and
consisted of either deletions of one to ﬁve bases, or, in
one case, a three-base insertion. Notably, three of these
errors occurred in pair junctions that matched a constant
vector overhang (as described above) where additional
steps for size-puriﬁcation were required. Mutations were
‘corrected’ by stepping back in the build tree and
re-assembling from sub-fragments that were veriﬁed as
error-free. In addition to size-verifying all subsequent
assembly products, the three ligation junctions between
vector and sub-fragments were sequence-veriﬁed to
ensure junction ﬁdelity.
The transition was made from high-copy to single-copy
PSA vectors at level 5 in the build tree due to the large size
(>45kb) of the PSA level 5 product. As anticipated, the
transition from pCK to pTSBAC was seamless, and the
correct product was selected based on resistance to tetra-
cycline and spectinomycin. At this level of the assembly
process, electroporation was used to increase the yield of
a transformed product. Size-veriﬁed level 5 sub-fragments
were combined in the ﬁnal assembly step to obtain
the full-length 91-kb construct (Figure 4). In the ﬁnal
assembly step, L and R sub-fragments contained
10 internal BsmBI sites and 19 internal BtgZI sites, respec-
tively. Size-veriﬁcation (Figure 4) and sequence-
veriﬁcation were both used to validate that the full-length
construct was correctly assembled. Despite verifying all
sub-fragments at PSA levels 0 and 3, a single C>T tran-
sition mutation was detected in the full-length product.
This mutation was not present in the fully sequenced
sub-fragment covering that region at PSA level 3, and is
not located at a junction between two sub-fragments,
possibly indicating that the mutation was generated
in vivo. Importantly, the full-length 91-kb construct
was selected in culture, indicating that the key features
of PSA, including reaction standardization, sequence-
independence and stringent selection, are scalable over a
sub-fragment range of  1.5–45kb.
Table 1. PSA details and yield for assembly of 91-kb synthetic chromosome arm
PSA
level
Number of
products
Average product
base pairs
Average (max.)
sites blocked per
sub-fragment
PSA vector Fraction (number) of products selected Total PSA
yield (%)
c
Culture
a Clonal/plate
b
0 64 1422 0.3 (2) pCK – – –
1 32 2844 0.8 (3) pTS 0.69 (22) 0.22 (7) 91
2 16 5688 1.4 (4) pCK 0.31 (5) 0.56 (9) 88
3 8 11376 3.0 (6) pTS 0.75 (6) 0 75
4 4 22752 5.5 (11) pCK 0.5 (2) 0.5 (2) 100
5 2 45504 14.5 (19) pTSBAC 0 1.0 (2) 100
6 1 91010 – pCKBAC 1.0 (1) – 100
aProducts selected in culture required a single digest screen.
bFor products that were not selected directly in culture, four cfu were grown and screened via digestion.
cPercent of products at each PSA level obtained from one round of culture/clonal screening.
M
(kb) CP 2 P1 L R
level 6
product
level 5
product
165 -
120 -
95 -
55 -
38 -
28 -
M
(kb)
Figure 4. Full-length synthetic chromosome arm. FIGE with  45-kb L
and R sub-fragments in pTSBAC, and the full-length synthetic chro-
mosome arm in pCKBAC selected in culture (C) or on plates (P1, P2).
DNA molecular weight marker (M) is a supercoiled BAC ladder
(Epicentre) enhanced to show contrast.
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We have demonstrated the utility of the PSA method by
constructing a completely synthetic 91-kb fragment of
DNA. This fragment, termed synIXR, is a completely syn-
thetic version of the right arm of the S. cerevisiae chromo-
some IX (J.S. Dymond et al., submitted for publication).
Yield of correctly paired sub-fragments, selected either
directly in culture, or on plates, was 89% (56 out of 63
products). The remaining seven products were constructed
using the fundamental PSA process, but required addi-
tional processing for sub-fragment puriﬁcation prior to
ligation (and in two cases, this puriﬁcation was suﬃcient
to enable selection in culture). A major failure mode
involved cases where the four-base junction between
sub-fragments matched one of the two destination vector
overhangs exactly. Propagation of the single sub-fragment
with vector-compatible ends may be due to spurious tran-
scription of the ‘promoter-less’ resistance marker from a
non-canonical promoter located within the insert DNA
(20). These cases are easily avoided in future assemblies
by ensuring that the 4bp sub-fragment junctions do not
include TTCA or TGAG sequences. Further constraints,
such as the elimination of palindromic overhangs, can be
placed on the junctions to minimize the titration of
sub-fragments into non-productive complexes which may
decrease the yield of a correctly ligated product. In
addition, future improvement to increase selectivity in
culture (e.g. by modifying the activation tags or selection
stringency) may facilitate more rapid construction by
further reducing or eliminating the need for clonal
isolation.
Importantly, the sequence-independent PSA method
enabled assembly of the entire 91-kb synIXR frag-
ment without introducing sequence modiﬁcations to
accommodate the construction method. Two common
type IIS enzymes were used together with a single
methyltransferase to excise sub-fragments with up to 19
internal sites. This advantage over conventional ligation-
based assembly methods becomes substantial when
designing and constructing pathway or chromosome-sized
DNA molecules where the tolerance for sequence modiﬁ-
cation is unknown. In addition, the high selectivity of the
PSA method minimizes the need for extensive handling
and puriﬁcation of such large fragments, limiting the
potential for DNA damage. The method was eﬀective
for pairing sub-fragments ranging from  1.5 to  45kb
and may be limited only by the ability to propagate an
assembled product in the chosen host. For example,
Gibson et al. found that in vitro assemblies greater than
 150kb were not recoverable in E. coli, and moved to
yeast as a more suitable host for assembly of a 583-kb
synthetic chromosome (16).
PSA will be a useful tool in the assembly of next gen-
eration synthetic gene networks (24), where rationally
designed libraries of components and pathways are
rapidly constructed and screened for function. For
example, combinatorial assembly of pathways and
pathway variants from native or engineered ‘modules’
consisting of promoters, genes and other regulatory
elements is feasible using pools of variant ‘L’ and ‘R’
sub-fragments rather than individual DNA molecules.
The key features of PSA, including hierarchical
assembly, reaction standardization and stringent selection
for a correct product make this process amenable to large-
scale, automated assembly of long-length DNA for a
variety of synthetic biology applications.
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